Diridavumab
N/A
Report date: 2023/11/30 20:02:39
Base Information
Drug NameDiridavumab
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[13]
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCrucell Holland Bv
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesJanssen Pharmaceutical KkCrucell Holland BvNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksWikipedia